Monday, April 9, 2018
Category: Immunocompromised Host, Infectious in Oncology, Pulmonary Infections, Transplant Infectious Diseases
Dr. Pasikhova discusses the history of the Pneumocystis pathogen, its epidemiology, and how it is transmitted to patients. She also discusses the pathophysiology of the infection in the context of the immunocompromised cancer patient. The role of steroids in the aquisition of PJP infection is touched upon. Lastly, Dr. Pasikhova describes prophylaxis against Pneumocystis, including specific agents and their usual doses.
Stay in touch! Download our app in the iTunes store or the Google Marketplace.